Tag: Starpharma

Starpharma Receives $7.1m R&D tax incentive refundBiopharmaceutical company Starpharma (SPL) receives a $7.1 million research and development tax incentive refund The tax offset...

Starpharma Registers VIRALEZE nasal spray in IndonesiaStarpharma (SPL) registers its nasal spray product VIRALEZE in Indonesia after gaining marketing authorisation The company says...

Starpharma Spends September quarter progressing DEP technologyStarpharma (SPL) spent the September quarter progressing its DEP technology and signing a new research agreement In...

Starpharma Expands research program with GenentechStarpharma (SPL) expands its research agreement with Genentech for its drug delivery technology, DEP The initial agreement was...

Starpharma Receives $7.7m R&D tax refundStarpharma (SPL) receives a $7.7 million research and development tax incentive refund The refund falls under the Australian...

Starpharma Continues VIRALEZE success in December quarterStarpharma (SPL) releases its September quarterly report, with the period again highlighted by the continued success of...